Yutaka Kato, Hiroshi Kawaguchi, Naoki Sakata, Satoshi Ueda, Munehiro Okano, Yuuki Nishino, . . . Satoshi Okada. (2023). Pirarubicin Combination Low-Dose Chemotherapy for Early Infantile Stage MS Neuroblastoma: Case Report. MDPI AG.
Chicago Style (17th ed.) CitationYutaka Kato, et al. Pirarubicin Combination Low-Dose Chemotherapy for Early Infantile Stage MS Neuroblastoma: Case Report. MDPI AG, 2023.
MLA (9th ed.) CitationYutaka Kato, et al. Pirarubicin Combination Low-Dose Chemotherapy for Early Infantile Stage MS Neuroblastoma: Case Report. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.